\n
1. Liver-Targeted Gene and Cell Therapies: An Overview.-
\n

Part I. Cell Therapy.-\n2. Macrophage Therapy for Liver Fibrosis and Regeneration.-\n3. Liver Regeneration Therapy Using Autologous Bone Marrow-Derived Cells for Cirrhotic Patients.-\n4. Novel Immunotherapy Using Liver Natural Killer Cells for Preventing Recurrence of Hepatocellular Carcinoma in Liver Transplantation.-\n5. Cell-Based Immunotherapy for HCC: Our Experiences and Future Directions.-

Part II. Gene Therapy.-\n6. AAV Vector-Mediated Liver Gene Therapy and Its Implementation for Hemophilia.-\n7. Potential Usage of Human Artificial Chromosome for Regenerative Medicine.-\n8. Image-Guided Hydrodynamic Gene Delivery to the Liver: Toward Clinical Applications.-

Part III. Legal Regulation\n9. The Way to Clinical Applications of Human Pluripotent Stem Cells.-\n10. Regulation for Gene and Cell Therapy Medicinal Products in Europe.-\n11. IPSC-Derived Products: Current Regulations.-\n12. Critical Path Initiative for Regenerative Medicine in Japan.-\n13. Aseptic Manufacturing of Regenerative Medicine Products Using Isolator Technology.-\n14. Cell and Vector Production Facility for Gene Therapy and Cell Therapy.